SMIN - ETF AI Analysis

Top Page

iShares MSCI India Small Cap ETF (SMIN)

Rating:59Neutral

Price Target:―

The iShares MSCI India Small Cap ETF (SMIN) has a moderate overall rating, reflecting a mix of strengths and challenges among its holdings. Embassy Office Parks REIT stands out as a key contributor, with strong financial performance, reasonable valuation, and a healthy dividend yield. However, weaker holdings like Glenmark Pharmaceuticals, which faces profitability volatility and bearish momentum, may have weighed on the fund's rating. A notable risk for this ETF is its exposure to overvalued stocks, as several holdings exhibit high P/E ratios and overbought technical signals.

Positive Factors

Strong Sector Diversification

The ETF is spread across multiple sectors, including materials, healthcare, and financials, reducing reliance on any single industry.

Focused Geographic Exposure

With nearly all assets invested in India, the fund provides targeted exposure to a growing emerging market economy.

Healthy Top Holdings Performance

Several top holdings, such as Fortis Healthcare and Laurus Labs, have shown strong year-to-date gains, supporting the fund’s potential recovery.

Negative Factors

High Expense Ratio

The ETF charges a relatively high fee compared to many other funds, which can eat into investor returns over time.

Weak Overall Performance

The fund has struggled recently, with negative year-to-date and three-month returns, signaling potential challenges in the small-cap segment.

Over-Concentration in India

The ETF’s heavy focus on Indian stocks limits diversification and increases vulnerability to country-specific risks.

SMIN vs. SPDR S&P 500 ETF (SPY)

AUM691.80M

RegionAsia-Pacific

Expense Ratio0.74%

Beta0.51

IssueriShares

Inception DateFeb 08, 2012

Dividend Yield2.07%

Asset ClassEquity

Index TrackedMSCI India Small Cap

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume117,022

30 Day Avg. Volume126,569

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SMIN Summary

The iShares MSCI India Small Cap ETF (SMIN) is an investment fund that focuses on small companies in India, offering exposure to the country’s fast-growing economy. It follows the MSCI India Small Cap Index, which includes businesses across various sectors like healthcare, financials, and technology. Some of its well-known holdings include Fortis Healthcare and Federal Bank. This ETF is ideal for investors looking to diversify their portfolio and tap into the growth potential of smaller, innovative companies in emerging markets. However, it’s important to note that small-cap stocks can be more volatile, meaning their value may rise and fall quickly.

How much will it cost me?The iShares MSCI India Small Cap ETF (SMIN) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is an actively managed fund focusing on small-cap stocks in India, which require more research and management compared to passively managed funds.

What would affect this ETF?The iShares MSCI India Small Cap ETF (SMIN) could benefit from India's strong economic growth and increasing innovation in sectors like technology and healthcare, which are key areas of exposure for the fund. However, risks include potential regulatory changes in India, global economic uncertainty, and the inherent volatility of small-cap stocks, which can be more sensitive to market fluctuations. Investors should also consider how interest rate changes or inflation could impact sectors like financials and consumer goods within the ETF.

SMIN Top 10 Holdings

The iShares MSCI India Small Cap ETF (SMIN) is riding the wave of India’s dynamic small-cap sector, with standout performers like Federal Bank and Laurus Labs driving gains thanks to their strong financial momentum and bullish technical signals. However, names like Coforge and KEI Industries are holding the fund back, with valuation concerns and mixed performance weighing on their contributions. The ETF leans heavily into financials and materials, reflecting India’s growth story, but its concentrated exposure to small-cap volatility means investors should brace for both exciting highs and potential dips.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
COFORGE	Coforge Limited	1.61%	$11.29M	₹563.44B	-3.68%	73 Outperform
MFSL	Max Financial Services Limited	1.36%	$9.59M	₹568.75B	55.17%	59 Neutral
FEDERALBNK	Federal Bank Ltd. (India)	1.35%	$9.49M	₹601.61B	26.36%	64 Neutral
LAURUSLABS	Laurus Labs Ltd.	1.15%	$8.08M	₹589.01B	95.60%	66 Neutral
EMBASSY	Embassy Office Parks REIT	1.12%	$7.88M	₹416.12B	16.74%	76 Outperform
GLENMARK	Glenmark Pharmaceuticals Limited	0.93%	$6.57M	₹567.65B	37.71%	53 Neutral
NATIONALUM	National Aluminium Co. Ltd.	0.93%	$6.52M	₹685.80B	88.02%	81 Outperform
MCX	Multi Commodity Exchange of India Limited	0.91%	$6.39M	₹616.58B	98.21%	72 Outperform
KEI	KEI Industries Limited	0.82%	$5.74M	₹419.28B	6.87%	63 Neutral
LTF	L&T Finance Ltd	0.78%	$5.46M	₹740.26B	107.91%	62 Neutral

SMIN Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

69.97

Negative

100DMA

71.01

Negative

200DMA

71.33

Negative

Market Momentum

MACD

-0.47

Positive

RSI

41.16

Neutral

STOCH

8.77

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 69.11, equal to the 50-day MA of 69.97, and equal to the 200-day MA of 71.33, indicating a bearish trend. The MACD of -0.47 indicates Positive momentum. The RSI at 41.16 is Neutral, neither overbought nor oversold. The STOCH value of 8.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SMIN.

SMIN Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SMIN	―	―	$691.80M	0.74%	―
INDA	―	―	$9.43B	0.61%	―
INDY	―	―	$631.47M	0.65%	―
PIN	―	―	$183.05M	0.78%	―
NFTY	―	―	$168.30M	0.80%	―
GIND	―	―	$136.16M	0.75%	―

Performance Comparison

SMIN

iShares MSCI India Small Cap ETF

67.98

-2.92

-4.12%

INDA

iShares MSCI India ETF

―

INDY

iShares India 50 ETF

―

Invesco India ETF

―

NFTY

First Trust India NIFTY 50 Equal Weight ETF

―

GIND

Goldman Sachs India Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents